Baidu
map

AP&T: 患有非酒精性脂肪肝的肥胖和非肥胖受试者的脂质组学的改变

2020-10-29 MedSci原创 MedSci原创

非酒精性脂肪肝疾病(NAFLD)是由肝甘油三酸酯(TGs)的异常积累引起的,这被称为单纯脂肪变性,有时可能会发展为非酒精性脂肪性肝炎(NASH)。

        非酒精性脂肪肝疾病(NAFLD)是由肝甘油三酸酯(TGs)的异常积累引起的,这被称为单纯脂肪变性,有时可能会发展为非酒精性脂肪性肝炎(NASH)和相关的纤维化。虽然肝甘油三酯的过度积累是已知的引发NAFLD的危险因素,但是尚不清楚非肥胖非酒精性脂肪性肝炎(NASH)的潜在机制,因此,本项研究旨在尝试使用脂质组学方法确定与非肥胖和肥胖NAFLD相关的代谢紊乱的相关性。

 

        研究人员对361名经活检证实的NAFLD(157名NAFL和138名NASH)和健康对照组(n = 66)进行了横断面分析。根据亚洲人的体重指数,将其分为肥胖或非肥胖。根据NAFLD的组织学严重程度进行循环血脂分析。使用独立的验证集(154名NAFLD受试者[93名NAFL和61名NASH]和21名健康对照)验证了循环脂质组学改变。

 

        在非肥胖的NAFLD患者中,饱和的鞘磷脂(SM)与内脏肥胖显着相关(SM d38:0;P  <0.001),而在肥胖的NAFLD中则没有。此外,SM水平与全身和脂肪组织的胰岛素抵抗显着相关(SM d38:0;P<0.001)。选择了非肥胖受试者的五种潜在脂质代谢物和肥胖受试者的七种潜在脂质来预测NAFLD和NASH。这些脂质组合对于非肥胖(NAFLD / NASH = 0.916 / 0.813的曲线下面积[AUC])和肥胖症(NAFLD / NASH = 0.967 / 0.812的AUC)表现出良好的诊断性能。

 

        本项研究最后作者说道:非肥胖和肥胖的NAFLD受试者表现出独特的循环脂质组学特征,包括甘油二脂(DAG),甘油三酯(TAG)和鞘磷脂(SM)的差异。这些脂质组合对于非肥胖和肥胖的NAFLD患者可能是有用的生物标志物。

 

 

原始出处:

Youngae Jung. Et al. Circulating lipidomic alterations in obese and non‐obese subjects with non‐alcoholic fatty liver disease. Alimentary Pharmacology and Therapeutics.2020.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1810302, encodeId=be8e181030215, content=<a href='/topic/show?id=5fb58444444' target=_blank style='color:#2F92EE;'>#脂质组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84444, encryptionId=5fb58444444, topicName=脂质组)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Mon Mar 22 00:11:04 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1676599, encodeId=b05416e659939, content=<a href='/topic/show?id=397299e19c7' target=_blank style='color:#2F92EE;'>#非酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99719, encryptionId=397299e19c7, topicName=非酒精性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Tue Aug 24 11:11:04 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1980568, encodeId=f9ef198056875, content=<a href='/topic/show?id=099f9548ed7' target=_blank style='color:#2F92EE;'>#酒精性脂肪肝#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95487, encryptionId=099f9548ed7, topicName=酒精性脂肪肝)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Tue Jun 15 12:11:04 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1673623, encodeId=854016e36237f, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Thu Apr 15 20:11:04 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446123, encodeId=f9bc144612360, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38075, encryptionId=23f4380e5f9, topicName=受试者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24035191312, createdName=xinmeili, createdTime=Sat Oct 31 06:11:04 CST 2020, time=2020-10-31, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1810302, encodeId=be8e181030215, content=<a href='/topic/show?id=5fb58444444' target=_blank style='color:#2F92EE;'>#脂质组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84444, encryptionId=5fb58444444, topicName=脂质组)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Mon Mar 22 00:11:04 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1676599, encodeId=b05416e659939, content=<a href='/topic/show?id=397299e19c7' target=_blank style='color:#2F92EE;'>#非酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99719, encryptionId=397299e19c7, topicName=非酒精性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Tue Aug 24 11:11:04 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1980568, encodeId=f9ef198056875, content=<a href='/topic/show?id=099f9548ed7' target=_blank style='color:#2F92EE;'>#酒精性脂肪肝#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95487, encryptionId=099f9548ed7, topicName=酒精性脂肪肝)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Tue Jun 15 12:11:04 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1673623, encodeId=854016e36237f, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Thu Apr 15 20:11:04 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446123, encodeId=f9bc144612360, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38075, encryptionId=23f4380e5f9, topicName=受试者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24035191312, createdName=xinmeili, createdTime=Sat Oct 31 06:11:04 CST 2020, time=2020-10-31, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1810302, encodeId=be8e181030215, content=<a href='/topic/show?id=5fb58444444' target=_blank style='color:#2F92EE;'>#脂质组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84444, encryptionId=5fb58444444, topicName=脂质组)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Mon Mar 22 00:11:04 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1676599, encodeId=b05416e659939, content=<a href='/topic/show?id=397299e19c7' target=_blank style='color:#2F92EE;'>#非酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99719, encryptionId=397299e19c7, topicName=非酒精性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Tue Aug 24 11:11:04 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1980568, encodeId=f9ef198056875, content=<a href='/topic/show?id=099f9548ed7' target=_blank style='color:#2F92EE;'>#酒精性脂肪肝#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95487, encryptionId=099f9548ed7, topicName=酒精性脂肪肝)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Tue Jun 15 12:11:04 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1673623, encodeId=854016e36237f, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Thu Apr 15 20:11:04 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446123, encodeId=f9bc144612360, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38075, encryptionId=23f4380e5f9, topicName=受试者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24035191312, createdName=xinmeili, createdTime=Sat Oct 31 06:11:04 CST 2020, time=2020-10-31, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1810302, encodeId=be8e181030215, content=<a href='/topic/show?id=5fb58444444' target=_blank style='color:#2F92EE;'>#脂质组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84444, encryptionId=5fb58444444, topicName=脂质组)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Mon Mar 22 00:11:04 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1676599, encodeId=b05416e659939, content=<a href='/topic/show?id=397299e19c7' target=_blank style='color:#2F92EE;'>#非酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99719, encryptionId=397299e19c7, topicName=非酒精性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Tue Aug 24 11:11:04 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1980568, encodeId=f9ef198056875, content=<a href='/topic/show?id=099f9548ed7' target=_blank style='color:#2F92EE;'>#酒精性脂肪肝#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95487, encryptionId=099f9548ed7, topicName=酒精性脂肪肝)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Tue Jun 15 12:11:04 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1673623, encodeId=854016e36237f, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Thu Apr 15 20:11:04 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446123, encodeId=f9bc144612360, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38075, encryptionId=23f4380e5f9, topicName=受试者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24035191312, createdName=xinmeili, createdTime=Sat Oct 31 06:11:04 CST 2020, time=2020-10-31, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1810302, encodeId=be8e181030215, content=<a href='/topic/show?id=5fb58444444' target=_blank style='color:#2F92EE;'>#脂质组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84444, encryptionId=5fb58444444, topicName=脂质组)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Mon Mar 22 00:11:04 CST 2021, time=2021-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1676599, encodeId=b05416e659939, content=<a href='/topic/show?id=397299e19c7' target=_blank style='color:#2F92EE;'>#非酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99719, encryptionId=397299e19c7, topicName=非酒精性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Tue Aug 24 11:11:04 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1980568, encodeId=f9ef198056875, content=<a href='/topic/show?id=099f9548ed7' target=_blank style='color:#2F92EE;'>#酒精性脂肪肝#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95487, encryptionId=099f9548ed7, topicName=酒精性脂肪肝)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26a9200, createdName=yangshch, createdTime=Tue Jun 15 12:11:04 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1673623, encodeId=854016e36237f, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Thu Apr 15 20:11:04 CST 2021, time=2021-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1446123, encodeId=f9bc144612360, content=<a href='/topic/show?id=23f4380e5f9' target=_blank style='color:#2F92EE;'>#受试者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38075, encryptionId=23f4380e5f9, topicName=受试者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=24035191312, createdName=xinmeili, createdTime=Sat Oct 31 06:11:04 CST 2020, time=2020-10-31, status=1, ipAttribution=)]

相关资讯

Cell Rep:灵芝衍生物或有望帮助治疗非酒精性脂肪肝!

研究报道了灵芝杂萜衍生物(GMD)的抗非酒精性脂肪性肝病的效应,研究者表示,GMD能增加拟杆菌属细菌的丰度从而激活拟杆菌属-叶酸-肝脏通路,进而减缓非酒精性脂肪肝患者的症状。

Clin Trans Gastroenterology:低热量饮食在非酒精性脂肪肝患者中可实现大于10%的减重目标

非酒精性脂肪性肝病(NAFLD)是全世界最常见的肝脏疾病,在西方国家中,估计有20%至33%的人口受到影响,这种情况与长期过量卡路里摄入有关。

AGING CELL:肝骨素对于预防非酒精性脂肪肝是必须的

在肝脏正常的个体中,研究人员观察到血清OPN水平与年龄的增加呈正相关。然而,在非酒精性脂肪肝患者中,这种与年龄的相关性却不存在。

Nat Commun:非肥胖性非酒精性脂肪肝中肠道微生物组与肝纤维化显著相关

非酒精性脂肪肝病(NAFLD)的特征表现为代谢紊乱,包括单纯性脂肪变性和非酒精性脂肪肝炎(NASH),最终会导致晚期肝纤维化和肝硬化。在大多数流行病学研究中,NAFLD的全球患病率约为24%至30%,

Br J Nutr:非酒精性脂肪肝患者长期补充营养保健品的疗效

本研究中,研究人员在非酒精性脂肪性肝病的受试者中探究了一种天然成分的混合物,即DHA、磷脂酰胆碱、水飞蓟素、胆碱、姜黄素和d-α-生育酚。主要终点为血清肝酶水平,其他肝功能参数、代谢综合征

Medicine:研究发现幽门螺杆菌感染会促进亚洲人群非酒精性脂肪肝的进展

目前尚未清楚幽门螺杆菌感染是否能促进非酒精性脂肪肝(NAFLD)的发生和发展。本研究旨在通过整合所有现有数据,评估幽门螺杆菌感染与非酒精性脂肪肝之间的确切关系,研究结果已在线发表于。

Baidu
map
Baidu
map
Baidu
map